| Literature DB >> 32072042 |
P G Bhavyasree1,2,3, T S Xavier2,3.
Abstract
Copper Oxide/Entities:
Keywords: Adhatoda vasica; Antimicrobial activity; Copper oxide/Carbon nano composites; Green synthesis; Materials science; Plant extract
Year: 2020 PMID: 32072042 PMCID: PMC7016239 DOI: 10.1016/j.heliyon.2020.e03323
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1The UV-visible spectrum of CuO/C nanocomposites.
Figure 2Powder XRD spectrum of CuO/C nanocomposites
Figure 3FTIR spectrum of Adhatoda vasica leaves and CuO/C nanocomposites
Figure 4SEM images of CuO/C nanocomposites obtained (a) under magnification of 25000 (b) under magnification of 50000 (c) under magnification of 150000 (d) under magnification of 150000 and labelled with porosity and flake thickness.
Figure 5EDS profile of CuO/C nanocomposites
Figure 6XPS signals of Cu2p.
Figure 7Deconvoluted XPS signal of C1s.
Figure 8XPS signals of O1s.
Figure 9TGA curve exhibiting weight loss (mg)against temperature under an air atmosphere.
Figure 10TGA curve exhibiting weight loss (mg)against temperature under nitrogen atmosphere.
Figure 11Photographs showing the zones of inhibition against the bacteria (a). E. coli (b). P. aeruginosa (c). K. pneumoniae (d). S. aureus and (e). S. mutans.
Figure 12Photographs showing the zones of inhibition against the fungi (a). A. niger and (b). C. albicans.
Zones of inhibition (in diameter) shown by different bacteria.
| Sample | Bacteria | Concentration (mg/ml) | Zone of inhibition |
|---|---|---|---|
| CuO/C nanocomposites | Streptomycin (1mg) | 23 | |
| 0.25 | Nil | ||
| 0.5 | Nil | ||
| 1.0 | 11 | ||
| Streptomycin (1mg) | 28 | ||
| 0.25 | Nil | ||
| 0.5 | Nil | ||
| 1.0 | 12 | ||
| Streptomycin (1mg) | 20 | ||
| 0.25 | Nil | ||
| 0.5 | Nil | ||
| 1.0 | 14 | ||
| Streptomycin (1mg) | 30 | ||
| 0.25 | Nil | ||
| 0.5 | Nil | ||
| 1.0 | 11 | ||
| Streptomycin (1mg) | 22 | ||
| 0.25 | Nil | ||
| 0.5 | Nil | ||
| 1.0 | Nil |
Zones of inhibition (in diameter) shown by different fungi.
| Sample | Organism | Concentration (mg/ml) | Zone of inhibition |
|---|---|---|---|
| CuO/C nanocomposites | Clotrimazole (1mg) | 22 | |
| 0.25 | 11 | ||
| 0.5 | 12 | ||
| 1.0 | 13 | ||
| CuO/C nanocomposites | Clotrimazole (1mg) | 22 | |
| 0.25 | 11 | ||
| 0.5 | 12 | ||
| 1.0 | 14 |
Percentage of inhibition against the bacteria K. pneumonia shown by the CuO/C nanocomposites in different concentrations.
| Organism: | ||
|---|---|---|
| Group | Absorbance | Percentage of Inhibition |
| Control | 0.2296 | 0.00 |
| CuO/C nanocomposites | ||
| 0.625 | 0.2175 | 7.45 |
| 0.125 | 0.1851 | 19.38 |
| 0.250 | 0.1751 | 23.74 |
| 0.5 | 0.1233 | 46.30 |
| 1.0 | 0.1033 | 55.14 |
Percentage of inhibition against the fungus C. albicans shown by the CuO/C nanocomposites in different concentrations.
| Organism: | ||
|---|---|---|
| Group | Absorbance | Percentage of Inhibition |
| Control | 0.2217 | 0.00 |
| CuO/C nanocomposites | ||
| 0.625 | 0.2123 | 4.24 |
| 0.125 | 0.2030 | 8.43 |
| 0.250 | 0.1670 | 24.67 |
| 0.5 | 0.1349 | 39.15 |
| 1.0 | 0.1069 | 51.78 |
Table exhibiting the MBC determination of CuO/C nanocomposites against K. pneumonia.
| Organism: | |
|---|---|
| Group | CFU/ml |
| Control | 4144 |
| CuO/C nanocomposites (mg/ml) | |
| 0.0625 | 116 |
| 0.125 | 92 |
| 0.25 | 56 |
| 0.5 | 40 |
| 1.0 | 12 |
| 1.5 | 1 |
| 2.0 | NIL |
Table exhibiting the MFC determination of CuO/C nanocomposites against C. albicans.
| Organism: | |
|---|---|
| Group | CFU/ml |
| Control | 424 |
| CuO/C nanocomposites (mg/ml) | |
| 0.0625 | 24 |
| 0.125 | 20 |
| 0.25 | 12 |
| 0.5 | 11 |
| 1.0 | 3 |
| 1.5 | NIL |
| 2.0 | NIL |
Figure 13Photographs showing the antibacterial activity of (a) control and CuO/C nanocomposites in different concentrations (b) 0.0625 mg/ml (c) 0.125 mg/ml(d) 0.250 mg/ml (e) 0.5 mg/ml (f) 1.0 mg/ml (g)1.5 mg/ml (h) 2.0 mg/ml against the bacteria K. pneumonia.
Figure 14Photographs showing the antifungal activity of (a) control and CuO/C nanocomposites in different concentrations (b) 0.0625 mg/ml (c) 0.125 mg/ml(d) 0.250 mg/ml (e) 0.5 mg/ml (f) 1.0 mg/ml (g)1.5 mg/ml (h) 2.0 mg/ml against the fungus C. albicans.